Latent Membrane Protein 1 (LMP1)

[Edit]

BNLF1; Protein p63

Latent Membrane Protein 1 (LMP1)
Latent membrane protein 1 (LMP1), which is critical for EBV-induced B-cell transformation, is also abundantly expressed during the lytic cycle of viral replication. Akata cell clones harboring the episomes of LMP1-deleted EBV were established, and the effect of LMP1 loss on virus production was investigated. Nucleocapsid formation inside nuclei occurred even in the absence of LMP1. By contrast, loss of LMP1 severely impaired virus release into culture supernatants, resulting in poor infection efficiency. The expression of truncated LMP1 in Akata cells harboring LMP1-deleted EBV rescued the virus release into the culture supernatant and the infectivity, and full-length LMP1 partially rescued the infectivity. These results indicate that inducible expression of LMP1 during the viral lytic cycle plays a critical role in virus production.

Organism species: Pan-species (General)

CATALOG NO. PRODUCT NAME APPLICATIONS
Proteins n/a Recombinant Latent Membrane Protein 1 (LMP1) Recombinant Protein Customized Service Offer
Antibodies n/a Monoclonal Antibody to Latent Membrane Protein 1 (LMP1) Monoclonal Antibody Customized Service Offer
n/a Polyclonal Antibody to Latent Membrane Protein 1 (LMP1) Polyclonal Antibody Customized Service Offer
Assay Kits n/a CLIA Kit for Latent Membrane Protein 1 (LMP1) CLIA Kit Customized Service Offer
n/a ELISA Kit for Latent Membrane Protein 1 (LMP1) ELISA Kit Customized Service Offer
  1. "Nucleotide sequence of an mRNA transcribed in latent growth-transforming virus infection indicates that it may encode a membrane protein."J. Virol. 51:411-419(1984) [PubMed] [Europe PMC] [Abstract]
  2. "Two related but differentially expressed potential membrane proteins encoded by the EcoRI Dhet region of Epstein-Barr virus B95-8."J. Virol. 53:528-535(1985) [PubMed] [Europe PMC] [Abstract]
  3. "DNA sequence and expression of the B95-8 Epstein-Barr virus genome."Nature 310:207-211(1984) [PubMed] [Europe PMC] [Abstract]
  4. "Posttranslational processing of an Epstein-Barr virus-encoded membrane protein expressed in cells transformed by Epstein-Barr virus."J. Virol. 61:866-875(1987) [PubMed] [Europe PMC] [Abstract]
  5. "Transformation of Balb 3T3 cells by the BNLF-1 gene of Epstein-Barr virus."Oncogene 2:461-467(1988) [PubMed] [Europe PMC] [Abstract]
  6. "Processing of the Epstein-Barr virus-encoded latent membrane protein p63/LMP."J. Virol. 64:829-837(1990) [PubMed] [Europe PMC] [Abstract]
  7. "The Epstein-Barr virus latent membrane protein-1 (LMP1) mediates activation of NF-kappa B and cell surface phenotype via two effector regions in its carboxy-terminal cytoplasmic domain."Oncogene 10:549-560(1995) [PubMed] [Europe PMC] [Abstract]
  8. "Degradation of the epstein-barr virus latent membrane protein 1 (LMP1) by the ubiquitin-proteasome pathway. Targeting via ubiquitination of the N-terminal residue."J. Biol. Chem. 275:23491-23499(2000) [PubMed] [Europe PMC] [Abstract]
  9. "BS69, a specific adaptor in the latent membrane protein 1-mediated c-Jun N-terminal kinase pathway."Mol. Cell. Biol. 26:448-456(2006) [PubMed] [Europe PMC] [Abstract]
  10. "IRF7 activation by Epstein-Barr virus latent membrane protein 1 requires localization at activation sites and TRAF6, but not TRAF2 or TRAF3."Proc. Natl. Acad. Sci. U.S.A. 105:18448-18453(2008) [PubMed] [Europe PMC] [Abstract]
  11. "BS69 negatively regulates the canonical NF-kappaB activation induced by Epstein-Barr virus-derived LMP1."FEBS Lett. 583:1567-1574(2009) [PubMed] [Europe PMC] [Abstract]
  12. "BS69 cooperates with TRAF3 in the regulation of Epstein-Barr virus-derived LMP1/CTAR1-induced NF-kappaB activation."FEBS Lett. 584:865-872(2010) [PubMed] [Europe PMC] [Abstract]
  13. "Epstein-Barr virus latent membrane protein 1 (LMP1) C-terminal-activating region 3 contributes to LMP1-mediated cellular migration via its interaction with Ubc9."J. Virol. 85:10144-10153(2011) [PubMed] [Europe PMC] [Abstract]
  14. "Epstein-Barr virus latent membrane protein 1 regulates the function of interferon regulatory factor 7 by inducing its sumoylation."J. Virol. 86:12251-12261(2012) [PubMed] [Europe PMC] [Abstract]
  15. "NF-kappaB and IRF7 pathway activation by Epstein-Barr virus Latent Membrane Protein 1."Viruses 5:1587-1606(2013) [PubMed] [Europe PMC] [Abstract]
  16. "Natural beta-sheet proteins use negative design to avoid edge-to-edge aggregation."Proc. Natl. Acad. Sci. U.S.A. 99:2754-2759(2002) [PubMed] [Europe PMC] [Abstract]